Chinese Academy of Medical Sciences
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial
- First Posted Date
- 2011-11-02
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 46
- Registration Number
- NCT01463605
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
- Conditions
- Hepatocellular Cancer
- Interventions
- Radiation: postoperative radiotherapy
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 76
- Registration Number
- NCT01456156
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT01444521
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 92
- Registration Number
- NCT01444547
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
- First Posted Date
- 2011-09-09
- Last Posted Date
- 2013-03-13
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 160
- Registration Number
- NCT01431053
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery
- Conditions
- Breast Cancer
- Interventions
- Radiation: radiotherapy
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 720
- Registration Number
- NCT01413269
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
🇨🇳Beijing hospital, Beijing, Beijing, China
🇨🇳Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
- Conditions
- Breast Cancer
- Interventions
- Drug: epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2011-12-28
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT01378533
- Locations
- 🇨🇳
Cancer institute and hospital Chinese academy of medical sciences, Beijing, Beijing, China
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
- Conditions
- HPV InfectionHIV InfectionSyphilis
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2011-02-23
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 3000
- Registration Number
- NCT01300689
- Locations
- 🇨🇳
Institute of Pathogen Biology (IPB), Beijing, Beijing, China
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
- First Posted Date
- 2011-02-08
- Last Posted Date
- 2013-09-18
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 27
- Registration Number
- NCT01291407
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
- Conditions
- Cancer
- Interventions
- Drug: pegylated filgrastim and filgrastimDrug: filgrastim and pegylated filgrastim
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2011-01-27
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 337
- Registration Number
- NCT01285219